JL Dienstag, JG McHutchison - Gastroenterology, 2006 - Elsevier In the United States, hepatitis C virus (HCV) infection accounts for
approximately 40% of all chronic liver disease, results in an estimated
8000–10,000 deaths annually, and is the most frequent indication for ... Cited by 161 - Related articles - All 17 versions
- ►va.gov [PDF] JA Davila, RO Morgan, Y Shaib, KA McGlynn, … - Gastroenterology, 2004 - Elsevier Background & Aims: A significantincrease in the incidence of hepatocellular
carcinoma (HCC) has been reported in the United States. The risk factors
underlying this increase remain unclear. Methods: By using Surveillance, ... Cited by 140 - Related articles - BL Direct - All 16 versions
- ►transpatica.org.br [PDF] CA Fleming, DE Craven, D Thornton, S … - Clinical Infectious Diseases, 2002 - UChicago Press Featured in New York Times "Searching the Web for Flu Outbreaks" November 28,
2008 Using Internet Searches for Influenza Surveillance Philip M. Polgreen,
Yiling Chen, David M. Pennock, and Forrest D. Nelson One study, published ... Cited by 94 - Related articles - BL Direct - All 7 versions
AZ Groeninge, B Kortrijk, NV Innogenetics, B … - Hepatology - interscience.wiley.com New treatments are needed for chronic hepatitis C patients in whom viral
clearance cannot be achieved. Thirty-five chronic hepatitis C patients (genotype
1) were randomized to receive 20 g of recombinant HCV E1 (E1) (n = 26) or ... Cited by 93 - Related articles - All 5 versions
S Allen, A Spaulding, JD Rich - Annals of internal medicine, 2004 - Am Coll Physicians References 1. Fisher ES, Wennberg DE, Stukel TA, Gottlieb DJ, Lucas FL, Pinder
EL. The implications of regional variations in Medicare spending. Part 1: the
content, quality, and accessibility of care. Ann Intern Med. 2003;138:273-87 ... Cited by 69 - Related articles - BL Direct - All 4 versions
- ►annals.org [PDF] SK Herrine - Annals of internal medicine, 2002 - Am Coll Physicians Chronic hepatitis C virus (HCV) infection is common and often asymptomatic.
Antibodies against HCV are a highly sensitive marker of infection. Molecular
testing for HCV is used to confirm a positive result on antibody testing ... Cited by 67 - Related articles - BL Direct - All 5 versions
R Chou, EC Clark, M Helfand - Annals of internal medicine, 2004 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Background: Hepatitis C virus (HCV) is the most common bloodborne pathogen ... Cited by 68 - Related articles - BL Direct - All 10 versions
DB Strader - Hepatology, 2002 - hawaii.edu Managing patients with hepatitis C virus (HCV) infection consists primarily of
antiviral treatment, currently with peginterferon and ribavirin. Unfortunately,
treatment recommen- dations derive largely from trials that have focused on ... Cited by 65 - Related articles - View as HTML - BL Direct - All 5 versions
T Hugle, A Cerny - Reviews in medical virology, 2003 - ingentaconnect.com Current therapeutic options for hepatitis C are limited, especially for genotype
1. For genotypes 2 and 3, pegylated interferon in combination with ribavirin,
can lead to a sustained virological response in up to 80% of patients. ... Cited by 56 - Related articles - BL Direct - All 4 versions
BL Pearlman - The American journal of medicine, 2004 - Elsevier Hepatitis C is a leading cause of chronic liver disease in the United States,
and the prevalence of hepatitis C–associated complications is increasing.
Therapy with pegylated interferon and ribavirin has become the standard of ... Cited by 54 - Related articles - All 11 versions
